Unknown

Dataset Information

0

Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis.


ABSTRACT: BACKGROUND:The pathogenesis of inflammatory bowel disease (IBD) is associated with a dysregulated mucosal immune response. Certain stimulators of innate immunity (CpG DNA or GM-CSF) are reported to be anti-inflammatory in IBD. Toll-like receptor-7 (TLR7) is an important regulator of innate immunity and its activation plays a key role in induction of type I interferon (IFN). The present study tests the hypothesis that the TLR7 agonists Imiquimod has therapeutic efficacy in IBD. METHODS:Acute colitis was induced in Balb/c mice by giving 5% dextran sodium sulfate (DSS) in drinking water for 7 days. Mice were treated with Imiquimod either orally or topically and its therapeutic effects on disease activity were examined. Isolated mouse CD11c+ dendritic cells and human intestinal epithelial cells (HT29, HCT116) were treated with Imiquimod (10 ?g/mL) and their susceptibility to intracellular Salmonella typhimurium infection was assessed by gentamicin protection assay. RESULTS:Oral administration of Imiquimod induced type I IFN expression in the gastrointestinal mucosa and ameliorated DSS-induced acute colitis as assessed by clinical parameters, histology, and mRNA expression of proinflammatory cytokines. Topical administration of Imiquimod also ameliorated DSS colitis by inducing the expression of type I IFN in the colonic mucosa. However, no evidence for a systemic IFN response was observed. Imiquimod treatments to both CD11c+ and intestinal epithelial cells significantly increased expression of antimicrobial peptides (AMPs) and reduced survival of intracellular S. typhimurium. CONCLUSIONS:Imiquimod induces type I IFN and AMP to ameliorate DSS-induced acute colitis and prevents Salmonella survival. Therefore, Imiquimod treatments provide a new therapeutic approach for IBD patients.

SUBMITTER: Sainathan SK 

PROVIDER: S-EPMC3878618 | biostudies-literature | 2012 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Toll-like receptor-7 ligand Imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis.

Sainathan Satheesh K SK   Bishnupuri Kumar S KS   Aden Konrad K   Luo Qizhi Q   Houchen Courtney W CW   Anant Shrikant S   Dieckgraefe Brian K BK  

Inflammatory bowel diseases 20110926 5


<h4>Background</h4>The pathogenesis of inflammatory bowel disease (IBD) is associated with a dysregulated mucosal immune response. Certain stimulators of innate immunity (CpG DNA or GM-CSF) are reported to be anti-inflammatory in IBD. Toll-like receptor-7 (TLR7) is an important regulator of innate immunity and its activation plays a key role in induction of type I interferon (IFN). The present study tests the hypothesis that the TLR7 agonists Imiquimod has therapeutic efficacy in IBD.<h4>Methods  ...[more]

Similar Datasets

| S-EPMC5648150 | biostudies-literature
| S-EPMC7376370 | biostudies-literature
| S-EPMC3236552 | biostudies-literature
| S-EPMC6168699 | biostudies-literature
| S-EPMC5875920 | biostudies-literature
| S-EPMC6866707 | biostudies-literature
| S-EPMC7457075 | biostudies-literature
| S-EPMC5478663 | biostudies-literature
| S-EPMC8399719 | biostudies-literature
| S-EPMC6083010 | biostudies-literature